Technical Analysis for BVXP - Bioventix Plc
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 20 DMA Support | Bullish | -1.57% | |
| Doji - Bullish? | Reversal | -1.57% | |
| 20 DMA Support | Bullish | -1.57% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | -1.57% | |
| Crossed Above 20 DMA | Bullish | -1.57% | |
| Inside Day | Range Contraction | -1.57% | |
| Gapped Up | Strength | -1.57% | |
| Fell Below 20 DMA | Bearish | 0.62% | |
| Outside Day | Range Expansion | 0.62% | |
| 20 DMA Support | Bullish | -3.04% |
| Alert | Time |
|---|---|
| Rose Above Previous Day's High | about 1 hour ago |
| Up 1% | about 1 hour ago |
| Down 2% | about 4 hours ago |
| 20 DMA Support | about 4 hours ago |
| Down 1% | about 6 hours ago |
Get this analysis on your stocks daily!
Bioventix Plc Description
Bioventix PLC is a United Kingdom-based biotechnology company. The principal activity of the Company is the development and supply of antibodies. The Company specializes in the development of sheep monoclonal antibodies (SMAs) for use in immunodiagnostics focusing on the areas of clinical diagnostics and drugs of abuse testing. The Company's non-vitamin D business consists of antibodies, NT proBNP (heart failure), testosterone, Free Triiodothyronine (FT3) (thyroid hormone), estradiol, and various drugs, such as tetrahydrocannabinol (THC)/cannabis, and progesterone. The Company offers products for indications, such as thyroid, fertility, oncology, cardiac, vitamin D, drug of abuse, infectious disease and miscellaneous. Its sheep hybridoma technology produces cell lines that secrete SMAs. The Company offers a panel of SMAs to 25-OH D and has various 25-OH D2 and 25-OH D3 specific antibodies. It sells its products through direct sales and through distributors.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Disease Branches Of Biology Medical Specialties Clinic Drugs Radio Oncology Testing Offers Products Monoclonal Antibodies Antibodies Infectious Disease Antibody Immunology E Testing Immune System Organ Systems Infectious Heart Failure Glycoproteins Monoclonal
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 5099.2461 |
| 52 Week Low | 3401.4971 |
| Average Volume | 4,439 |
| 200-Day Moving Average | 4124.05 |
| 50-Day Moving Average | 4704.49 |
| 20-Day Moving Average | 4563.03 |
| 10-Day Moving Average | 4596.73 |
| Average True Range | 141.11 |
| RSI (14) | 49.49 |
| ADX | 17.73 |
| +DI | 14.50 |
| -DI | 15.07 |
| Chandelier Exit (Long, 3 ATRs) | 4359.95 |
| Chandelier Exit (Short, 3 ATRs) | 4822.69 |
| Upper Bollinger Bands | 4709.48 |
| Lower Bollinger Band | 4416.58 |
| Percent B (%b) | 0.63 |
| BandWidth | 6.42 |
| MACD Line | -17.19 |
| MACD Signal Line | -26.78 |
| MACD Histogram | 9.5823 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 4778.50 | ||||
| Resistance 3 (R3) | 4765.00 | 4692.00 | 4748.75 | ||
| Resistance 2 (R2) | 4692.00 | 4646.54 | 4698.75 | 4738.83 | |
| Resistance 1 (R1) | 4646.00 | 4618.46 | 4659.50 | 4659.50 | 4728.91 |
| Pivot Point | 4573.00 | 4573.00 | 4579.75 | 4579.75 | 4573.00 |
| Support 1 (S1) | 4527.00 | 4527.54 | 4540.50 | 4540.50 | 4471.09 |
| Support 2 (S2) | 4454.00 | 4499.46 | 4460.75 | 4461.17 | |
| Support 3 (S3) | 4408.00 | 4454.00 | 4451.25 | ||
| Support 4 (S4) | 4421.50 |
